Holder evidence
50
SEC ownership of BELLICUM PHARMACEUTICALS, INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001358403.
Lead holder
ARMISTICE CAPITAL, LLC
13D/G signal
ARMISTICE CAPITAL, LLC
Latest evidence
31 Mar 2026
- CIK
- 0001358403
- Location
- Houston, TX
- SEC evidence mix
- 13D/G and 13F
- Lead holder
- ARMISTICE CAPITAL, LLC
- Latest large-stake holder
- ARMISTICE CAPITAL, LLC
- Latest evidence date
- 31 Mar 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of BELLICUM PHARMACEUTICALS, INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
ARMISTICE CAPITAL, LLC
13D/G signal
ARMISTICE CAPITAL, LLC
Evidence rows
50
Latest as of
31 Mar 2026
13D/G
13F
Lead comparable stake: 10%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-8 of 50 holder rows.
Rank 1 holder
ARMISTICE CAPITAL, LLC
13D/G
- Ownership
- 10%
- Position
- $1.15M
Rank 2 holder
JANE STREET GROUP, LLC
13F
- Ownership
- 3.5%
- Position
- $40.84M
Rank 3 holder
Situational Awareness LP
13F
- Ownership
- 3.3%
- Position
- $38.76M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
|
$1,153,951
1,078,459 shares
|
$0 | 30 Jun 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
3.5%
|
$40,840,280
20,818,071 shares
|
— | 31 Mar 2026 |
| Situational Awareness LP |
13F
Company
|
3.3%
|
$38,757,888
19,875,840 shares
|
— | 31 Mar 2026 |
| Situational Awareness Partners LP |
13F
Company
|
3.3%
|
$38,757,888
19,875,840 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.3%
|
$26,452,165
13,565,213 shares
|
— | 31 Mar 2026 |
| Invesco Ltd. |
13F
Company
|
2%
|
$23,448,850
12,025,051 shares
|
— | 31 Mar 2026 |
| Point72 Asset Management, L.P. |
13F
Company
|
2%
|
$22,637,918
11,612,813 shares
|
— | 31 Mar 2026 |
| CastleKnight Management LP |
13F
Company
|
1.8%
|
$21,245,190
10,894,969 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to BELLICUM PHARMACEUTICALS, INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Lead holder
Stephen Davis
Net 12M change
$0
Latest report
22 Nov 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Stephen Davis | Director | Mixed | 03 Jan 2023 | |||
| Jon P. Stonehouse | Director | Mixed | 03 Jan 2023 | |||
| James F. Brown | Director | Mixed | 04 Jan 2022 | |||
| Reid M. Huber | Director | Mixed | 03 Jan 2023 | |||
| Richard A. Fair | President and CEO, Director | Mixed | 15 Aug 2022 | |||
| Charity Scripture | Chief Development Officer | Mixed | 15 Aug 2022 | |||
| James M. Daly | Director | Mixed | 03 Jan 2023 | |||
| Charles S. Grass | Principal Accounting Officer | Mixed | 11 May 2021 | |||
| Judith Klimovsky V | Director | Mixed | 03 Jan 2023 | |||
| BAKER BROS. ADVISORS LP | 10%+ Owner | Mixed | 22 Nov 2023 |
Recent insider transactions for BELLICUM PHARMACEUTICALS, INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.